Ontology highlight
ABSTRACT:
SUBMITTER: Saxena A
PROVIDER: S-EPMC4524771 | biostudies-literature | 2015 Aug
REPOSITORIES: biostudies-literature
Saxena Ashish A Becker Daniel D Preeshagul Isabel I Lee Karen K Katz Elena E Levy Benjamin B
The oncologist 20150708 8
The recent emergence of targeted and immunotherapeutic agents has dramatically changed the management for patients with non-small cell lung cancer (NSCLC). Despite these advances, lung cancer is not exempt from the challenges facing oncology drug development, including the huge financial cost and the time required for drug implementation. Repositioning noncancer therapies with potential antineoplastic properties into new therapeutic niches is an alternative treatment strategy offering the possib ...[more]